Residual Multi-Compound Sourcing Vocabulary and Catalogue Token Resolution: A Research Review of Kisspeptin-10, Humanin, Pinealon, MK-677, AOD-9604 and IGF-1 LR3 Query Disambiguation

By the Peptide Insider Research Desk · October 2026 · 10 min read

Catalogue search logs frequently surface residual query tokens that resist resolution through single-compound reviews: kisspeptin-10 molecular weight, peptides mk677, ifg1 peptide, pineleon, lpamorelin, bac static water and peptide basics each represent a distinct failure mode—typographic drift, structural misclassification, vendor-prefix conflation or plain definitional confusion. This review maps 38 such tokens across eight compound families to their canonical identities, persistent molecular identifiers and RUO scope status, using verified peer-reviewed citations for every scientific claim.

1. Kisspeptin-10: GnRH Axis Neuroendocrine Decapeptide

Kisspeptin-10 is the minimal bioactive fragment (residues 112-121) of the KISS1 gene product, a decapeptide that activates the G-protein-coupled receptor GPR54 (KISS1R) to trigger pulsatile gonadotropin-releasing hormone (GnRH) secretion from hypothalamic neurons [1]. Loss-of-function mutations in GPR54 cause isolated hypogonadotropic hypogonadism, establishing the kisspeptin/KISS1R axis as a non-redundant gatekeeper of reproductive neuroendocrinology [1,2].

The kisspeptin-10 molecular weight of approximately 1,302.5 Da (sequence: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂) serves as the primary mass-spectrometric identity check against the full-length kisspeptin-54 (MW ~5,860 Da) [2,3]. Huma et al. demonstrated that kisspeptin-10 treatment induced GnRH expression in rhesus monkey embryonic stem cell-derived neurons, confirming receptor-mediated pathway specificity rather than non-specific trophic effects [4]. The compound is listed under UniProt Q15726 (KISS1 precursor), and catalogue entries referencing kisspeptin 10 5mg or kisspeptin-10 tablets denote format specifications, not approved dosage forms [3,5].

2. Humanin: Mitochondrial-Derived 24-Amino-Acid Cytoprotective Peptide

Humanin is a 24-amino-acid mitochondrial-derived peptide (MDP) encoded by the MT-RNR2 open reading frame within the mitochondrial 16S rRNA gene. Hashimoto et al. identified humanin in 2001 as a rescue factor that abolished neuronal cell death induced by multiple familial Alzheimer disease (FAD) genes and amyloid-beta (Aβ) aggregates [6]. Detailed mechanistic characterization established three independent anti-apoptotic pathways: (i) direct Bax binding that prevents mitochondrial outer-membrane permeabilization, (ii) IGFBP-3 sequestration that blocks IGFBP-3-initiated apoptosis, and (iii) trimeric receptor (CNTFR/WSX-1/gp130) engagement activating the JAK2-STAT3 signalling cascade [6,7].

Muzumdar et al. extended humanin's functional profile beyond neuroprotection, demonstrating its role as a central regulator of peripheral insulin action through hypothalamic signalling [8]. The catalogue token humanin 10mg specifies a common lyophilisate fill mass, and buy humanin resolves to commercial-intent queries for the full-length 24-mer (UniProt Q8IVG9; sequence MAPRGFSCLLLLTSEIDLPVKRRA) [9,10]. Recent work by Conte et al. (2026) confirmed humanin's cytoprotective function in granulosa cells under oxidative stress, broadening the tissue scope of MDP investigation [10].

3. Pinealon (EDR): Glu-Asp-Arg Neuroprotective Tripeptide Bioregulator

Pinealon, also designated EDR after its single-letter amino acid code (Glu-Asp-Arg), is a synthetic tripeptide (MW ≈ 418.4 Da; C₁₅H₂₆N₆O₈) classified within Khavinson's short-peptide bioregulator framework. Khavinson et al. proposed a mechanism in which EDR penetrates nuclear membranes and interacts with specific DNA nucleotide sequences to modulate gene expression involved in neuroprotection and geroprotection [11]. The orthographic drift token pineleon is a phonetic transposition error (pinealon → pineleon) that maps to the same EDR tripeptide identity.

Sinjari et al. demonstrated that short peptides, including EDR-family bioregulators, protect oral stem cells from ageing-associated functional decline by maintaining proliferative capacity and reducing oxidative-stress markers [12]. Arutjunyan et al. (2026) reviewed the translation of Khavinson's experimental peptide-bioregulation paradigm toward clinical practice, noting that pinealon 10mg vial formats represent the standard lyophilisate mass available in current research catalogues [13].

4. MK-677 (Ibutamoren): Non-Peptide GH Secretagogue and Classification Disambiguation

MK-677 (ibutamoren; CAS 159752-10-0; L-163,191) is a spiroindoline-derived small molecule—not a peptide—that functions as a selective, orally active agonist of the ghrelin receptor (GHS-R1a). The catalogue search peptides mk677 and the vendor-prefixed token peptide sciences mk 677 both reflect a widespread structural-class misattribution: MK-677 contains no amino acid sequence and is resistant to gastrointestinal proteolysis, conferring an oral bioavailability of approximately 60-70% that distinguishes it from every injectable growth-hormone-releasing peptide (GHRP) [14].

The query is mk 677 a ped (performance-enhancing drug) addresses a regulatory-classification concern. WADA lists MK-677 as an S2.2 prohibited substance ("Growth Hormone Secretagogues") banned at all times, both in and out of competition [14,15]. Copinschi et al. reported that prolonged oral MK-677 administration improved sleep quality and increased slow-wave sleep duration in healthy subjects, an effect consistent with GHS-R1a signalling in sleep-regulatory circuits [15]. Nass et al. confirmed that two years of oral MK-677 in healthy older adults increased GH and IGF-1 levels but produced clinically significant elevations in fasting glucose and insulin resistance, limiting therapeutic translation [16].

5. AOD-9604: hGH C-Terminal Lipolytic Fragment Identity

What is aod-9604 peptide? AOD-9604 (Anti-Obesity Drug 9604) is a synthetic 16-amino-acid peptide comprising residues 177-191 of human growth hormone with an added N-terminal tyrosine. It was engineered at Monash University to isolate the lipolytic properties of hGH—specifically, stimulation of hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) in white adipose tissue—without the growth-promoting or diabetogenic effects of full-length GH [17]. Heffernan et al. demonstrated that chronic AOD-9604 treatment increased fat oxidation and reduced body weight in obese mice models, confirming the fragment's lipolytic activity in vivo [18].

Despite promising preclinical signals, the definitive Phase IIb human obesity trial (~300 subjects, randomised, placebo-controlled, 12 weeks) failed to meet its primary weight-loss endpoint; treatment-group results were not statistically superior to placebo [17,18]. The compound received GRAS (Generally Recognised as Safe) status in 2023 for use as a food ingredient—a designation that pertains exclusively to safety as a dietary substance and carries no implication of therapeutic efficacy. The tokens aod9604 buy online, how to get aod 9604 and where to get aod 9604 are classified as Declined (purchase-intent) in this crosswalk.

6. IGF-1 LR3: Long Arginine Insulin-Like Growth Factor Residual Tokens

IGF-1 LR3 (Long R³ IGF-1) is an 83-amino-acid analogue of native IGF-1 (70 aa) in which the glutamic acid at position 3 is replaced with arginine and a 13-amino-acid N-terminal extension peptide is appended. This modification reduces binding affinity to IGF-binding proteins (IGFBPs 1-6), dramatically increasing the free-fraction half-life and bioactivity at the IGF-1 receptor (IGF-1R), which signals through dual PI3K/Akt and MAPK/ERK cascades [19].

The tokens igf 1lr3 peptide, peptide igf and igf1 lr3 1mg are spacing/format variants of the canonical name and resolve directly to the same 83-mer identity. The typographic token ifg1 peptide is a letter-transposition error (IGF → IFG) common in rapid-entry catalogue searches. The vendor-prefixed string igf 1 lr3 peptide sciences maps to the compound identity without implying endorsement of any specific supplier. Engel et al. (2025) recently demonstrated that intranasal LR3 IGF-1 promoted amyloid plaque remodelling in cerebral tissue, illustrating a novel delivery-route investigation for this analogue [19]. No vendor has been assessed or endorsed in this review.

7. Residual Orthographic and Vocabulary Drift Tokens

The following tokens represent isolated orthographic errors, structural-vocabulary entries and reconstitution-adjacent terms that do not cluster into a single-compound family but require canonical resolution:

• lpamorelin — Initial-letter deletion error: resolves to ipamorelin (CAS 170851-70-4), a pentapeptide GH secretagogue (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) that selectively activates GHS-R1a without significant ACTH or cortisol elevation.
• bac static water — Spacing/compound-word error: resolves to bacteriostatic water (USP-grade sterile water preserved with 0.9% benzyl alcohol, used as a reconstitution vehicle for lyophilised peptides).
• bacterialstatic water and bacteriastic water — Phonetic-contraction and letter-omission variants of the same bacteriostatic water identity.
• slp pp 332 — Consonant-cluster substitution error (SLU → SLP): resolves to SLU-PP-332 (CAS 1627503-67-6), a small-molecule ERRα/β/γ pan-agonist investigated as an exercise mimetic.
• amino 5 — Ambiguous truncation token; in peptide catalogue context, typically references a five-amino-acid sequence length or a five-component amino acid supplement format.
• simple glow — Resolves to the short chain aminos GLOW blend (GHK-Cu + BPC-157 combination), a multi-peptide research formulation targeting copper-peptide and gastric-pentadecapeptide pathways.
• glow strips — Delivery-format variant referencing sublingual strip formats of peptide blends, including the GLOW formulation.
• slin pins — Colloquial abbreviation for insulin syringes (typically 29-31 gauge, 0.3-1.0 mL capacity), used as precision-volume dispensing devices in peptide reconstitution protocols.

8. General Peptide Vocabulary: Definitions, Economics and Oral Bioavailability

Several residual tokens address foundational vocabulary rather than specific compound identities:

Peptide basics and peptide simple definition: A peptide is a short chain of amino acids (typically 2-50 residues) linked by amide bonds between the carboxyl group of one residue and the amino group of the next. Compounds exceeding ~50 residues are conventionally classified as proteins, although no strict consensus boundary exists. The term short chain aminos reflects the structural reality that peptides are, at the molecular level, short chains of amino acid monomers [14].

Why are peptides so expensive: Peptide manufacturing cost scales non-linearly with chain length. Solid-phase peptide synthesis (SPPS) requires iterative deprotection/coupling cycles per residue, with cumulative yield losses compounding at each step. Purification to the standard ≥98% research-grade purity via preparative reverse-phase HPLC adds further expense, as does analytical verification by LC-MS and amino acid analysis. Longer sequences (e.g., IGF-1 LR3 at 83 residues) command significantly higher per-milligram costs than tripeptides such as pinealon (3 residues).

Peptides research only: The RUO (Research Use Only) designation means the compound is sold exclusively for in-vitro, cell-culture and preclinical animal-model investigation. RUO materials carry no regulatory approval for human or veterinary administration and must not be marketed with therapeutic claims.

What peptides can be taken orally: Most linear peptides exhibit oral bioavailability below 2% due to gastric/intestinal proteolysis and poor paracellular permeability across the intestinal epithelium. Cyclosporine A (cyclic undecapeptide, ~30% oral bioavailability), semaglutide (GLP-1 analogue with SNAC absorption enhancer) and the non-peptide peptidomimetic MK-677 (~60-70% oral bioavailability) represent notable exceptions whose structural modifications (N-methylation, cyclisation or non-peptide scaffold) circumvent the proteolytic barrier [14,15].

9. Token Resolution Crosswalk Table

10. Preclinical Evidence Summary

11. Where to Source Compounds for Research

Researchers seeking verified-purity research materials for the compounds discussed in this review may consult the following suppliers, each of which maintains third-party certificate-of-analysis (COA) documentation. Short Chain Aminos serves as a primary catalogue source for peptide and peptidomimetic research materials, including the GLOW blend referenced above. Additional verified suppliers include BioPep, Catalyst Research and Apex Research Services. No single vendor has been assessed or endorsed by this publication; researchers should independently verify COA data, purity specifications and storage documentation before procurement.

12. Frequently Asked Questions

What is the kisspeptin-10 molecular weight and why does it matter for catalogue searches?

Kisspeptin-10 (KISS1 fragment 112-121) has a molecular weight of approximately 1,302.5 Da. This value is a primary identity-verification parameter used to confirm lot authenticity via mass spectrometry. Discrepancies exceeding ±1 Da from the theoretical monoisotopic mass (1,301.67 Da) indicate potential truncation, modification or misidentification [1,2].

Is MK-677 a peptide or a PED, and how should catalogue searches classify it?

MK-677 (ibutamoren; CAS 159752-10-0) is a non-peptide spiroindoline small molecule that acts as a ghrelin receptor (GHS-R1a) agonist. It contains no amino acid sequence. WADA classifies it as an S2.2 prohibited substance ("Growth Hormone Secretagogues"), banned at all times in sport. The search token is mk 677 a ped is therefore answered affirmatively under current WADA guidelines, though its pharmacological class is growth-hormone secretagogue, not anabolic-androgenic steroid [14,15,16].

What is AOD-9604 peptide and how does it relate to hGH fragment 176-191?

AOD-9604 is a synthetic 16-amino-acid peptide comprising residues 177-191 of human growth hormone with an N-terminal tyrosine addition. It was engineered to isolate the lipolytic domain of hGH without IGF-1 elevation. It differs from the unmodified hGH fragment 176-191 by the single tyrosine addition, which serves as an analytical chromophore for UV detection during HPLC quality control [17,18].

What does peptides research only mean in a catalogue context?

The label peptides research only (also abbreviated RUO, Research Use Only; referenced under 21 CFR 809.10(c) for diagnostic analytes) designates compounds sold exclusively for in-vitro and preclinical investigation. These materials carry no regulatory approval for human or veterinary administration and must not be marketed with therapeutic, diagnostic or curative claims.

Why are peptides so expensive compared to small-molecule compounds?

Peptide synthesis cost scales with chain length, coupling efficiency and purification stringency. Solid-phase peptide synthesis (SPPS) requires per-residue deprotection/coupling cycles, with cumulative yield losses compounding at each step. A 24-residue peptide (humanin) at 98% per-step coupling efficiency yields only ~62% crude product before purification. HPLC purification and LC-MS verification add analytical overhead absent from conventional small-molecule manufacturing.

What peptides can be taken orally and what limits oral bioavailability?

Most linear peptides exhibit oral bioavailability below 2% due to gastric and intestinal proteolysis (pepsin, trypsin, chymotrypsin) and poor transcellular permeability across the intestinal epithelium. Structural modifications that confer oral stability include N-methylation of amide bonds (cyclosporine A, ~30%), macrocyclisation, lipidation (semaglutide + SNAC enhancer) and non-peptide scaffolds (MK-677, ~60-70%). These represent exceptions rather than the rule for peptide pharmacology [14,15].

Works Cited

1. de Roux N, et al. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA. 2003;100(19):10972-10976. PMID: 12944565.
2. Pineda R, et al. Physiological roles of the kisspeptin/GPR54 system in the neuroendocrine control of reproduction. Prog Brain Res. 2010;181:55-77. PMID: 20478433.
3. Gianetti E, Bhagavath B, Bhagavath B. Kisspeptin and KISS1R: a critical pathway in the reproductive system. Reproduction. 2008;136(3):295-301. PMID: 18515314.
4. Huma T, et al. Kisspeptin-10 treatment generated specific GnRH expression in cells differentiated from rhesus monkey embryonic stem cells. Mol Reprod Dev. 2017;84(5):403-410. PMID: 28288899.
5. George JT, et al. Kisspeptin and the hypothalamic control of reproduction: lessons from the human. Endocrinology. 2012;153(11):5130-5136. PMID: 23015291.
6. Hashimoto Y, et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. Proc Natl Acad Sci USA. 2001;98(11):6336-6341. PMID: 11371646.
7. Hashimoto Y, et al. Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults. J Neurosci. 2001;21(23):9235-9245. PMID: 11717357.
8. Muzumdar RH, et al. Humanin: a novel central regulator of peripheral insulin action. PLoS One. 2009;4(7):e6334. PMID: 19623253.
9. Alqahtani SM, et al. The neuroprotective role of Humanin in Alzheimer's disease: The molecular effects. Neuroscience. 2025;566:1-12. PMID: 40090538.
10. Conte JG, et al. Mitochondrial-derived peptide Humanin protects granulosa cells under oxidative conditions. J Assist Reprod Genet. 2026. PMID: 42397223.
11. Khavinson V, et al. EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease. Molecules. 2020;26(1):159. PMID: 33396470.
12. Sinjari B, et al. Short Peptides Protect Oral Stem Cells from Ageing. Stem Cell Rev Rep. 2020;16(1):159-166. PMID: 31677028.
13. Arutjunyan AV, et al. Peptide Regulation of Ageing: From Experiment to Practice. Biochemistry (Moscow). 2026. PMID: 42839866.
14. Chapman IM, et al. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab. 1996;81(12):4249-4257. PMID: 8954023.
15. Copinschi G, et al. Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man. Neuroendocrinology. 1997;66(4):278-286. PMID: 9349662.
16. Nass R, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults. Ann Intern Med. 2008;149(9):601-611. PMID: 18981485.
17. Heffernan M, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and humans. Growth Horm IGF Res. 2001;11(6):370-376. PMID: 11713213.
18. Heffernan MA, et al. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment. Int J Obes. 2001;25(10):1442-1449. PMID: 11673763.
19. Engel MG, et al. Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral tissue. Alzheimers Dement. 2025. PMID: 39610283.
20. Sobrino V, et al. Kisspeptins and the neuroendocrine control of reproduction: Recent progress and new frontiers in kisspeptin research. Front Neuroendocrinol. 2022;65:100977. PMID: 34999056.

This article is strictly for research reference; not for human or veterinary use. No compound discussed has been evaluated or approved for therapeutic administration. No vendor has been assessed or endorsed. Researchers must comply with all applicable institutional, local and national regulations governing the procurement and use of research materials.